Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue to challen...

Full description

Bibliographic Details
Main Authors: Loos, Carolin, Atyeo, Caroline, Fischinger, Stephanie, Burke, John, Slein, Matthew D., Streeck, Hendrik, Lauffenburger, Douglas A, Ryan, Edward T., Charles, Richelle C., Alter, Galit
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Published: American Society for Microbiology 2020
Online Access:https://hdl.handle.net/1721.1/127199

Internet

https://hdl.handle.net/1721.1/127199

Similar Items